China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. Our core capabilities include plasma collection, research and development, manufacturing, and commercialization of human plasma-based biopharmaceutical products. Our company was founded in 2002 and was listed on NASDAQ in 2009.… More >>